Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $16.1 billion versus the consensus estimate of $16.26 billion.

Sees FY2012 EPS of $5.07-$5.17, versus prior guidance of $5.05-$5.15 and the consensus of $5.11.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

Earnings Guidance Hot List